• Research, Science, and Trials

  Gene Therapy

  Posted by Christina Cordaro on October 27, 2020 at 8:55 am

  AavantiBio, a gene therapy company, launches a $107 Million Series A Financing from Perceptive Advisors with Bain Capital Life Sciences, RA Capital Management and Sarepta Therapeutics.

  AavantiBio will pursue a diversified gene therapy pipeline, including a lead program in Friedreich’s Ataxia (FA).

  To read more, please click here: https://www.globenewswire.com/news-release/2020/10/22/2112705/0/en/Gene-Therapy-Company-AavantiBio-Launches-with-107-Million-Series-A-Financing-from-Perceptive-Advisors-Bain-Capital-Life-Sciences-RA-Capital-Management-and-Sarepta-Therapeutics.html

  Christina Cordaro replied 4 years, 2 months ago 1 Member · 0 Replies

  • gene therapy
  • progress
  • scientific news
• 0 Replies

Log In to Reply